Iterum Therapeutics (ITRM) Commences Rights Offering

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/9/2026

1. SPCX
2. HUM
3. ALHC
4. T
5. PEP
6. CVS
7. UNH
8. SBUX
9. AXP
10. ZETA

Go back to Iterum Therapeutics (ITRM) Commences Rights Offering

Iterum Therapeutics Commences Rights Offering

July 22, 2024 7:30 AM EDT

DUBLIN and CHICAGO, July 22, 2024 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage pharmaceutical company focused on developing next generation oral and IV antibiotics to treat infections caused by multi-drug resistant pathogens in both community and hospital settings, today announced that it has commenced its previously disclosed rights offering (the Rights Offering).

Pursuant to the Rights Offering, the Company is distributing, at no charge, subscription rights to the Companys shareholders and holders of warrants that have contractual rights to participate in the Rights Offering which have... More